What did @itsmejadeb actually say?
She's been on tirzepatide for roughly six weeks at 2.5 mg, the starting dose, and says her primary goal isn't rapid weight loss but wanting to "feel normal again." Her big claims: her face looks slimmer even though she hasn't lost much weight, she feels "so much less inflamed," and she's lost her desire to drink alcohol, even getting sick after two martinis. She also says she's intentionally staying "low and slow" on dosing.
To her credit, she's not claiming tirzepatide cured anything specific. She's describing how she feels, which is actually more honest than a lot of GLP-1 content on this platform. But "I feel less inflamed" and "my face is slimmer" are doing real scientific work in this video that deserves some scrutiny.
Does the science back this up?
Partially, yes, and that's the interesting part. The inflammation piece is not pure vibes. There is legitimate early evidence that tirzepatide reduces inflammatory markers, and the alcohol aversion is a documented, if not fully understood, side effect. But she's conflating a few different things and the mechanism matters.
On inflammation: tirzepatide acts on both GIP and GLP-1 receptors, and research has shown it reduces C-reactive protein (CRP) and interleukin-6 in people with obesity and type 2 diabetes. Ludvik et al. (2021, The Lancet) documented significant reductions in inflammatory biomarkers in the SURPASS trials. However, those reductions tracked closely with weight loss itself. It's genuinely hard to separate "tirzepatide reduced inflammation" from "losing weight reduced inflammation." She says she hasn't lost much weight yet, which makes her inflammation claim harder to verify and frankly a little suspicious.
On facial slimming without weight loss: this could reflect reduced water retention or redistribution of fluid, which GLP-1 receptor agonists can influence through effects on sodium excretion and appetite-driven fluid intake. It's plausible, not proven in her specific case.
What did they get wrong (or right)?
She got the alcohol piece mostly right by accident. The nausea after two martinis is a real and documented phenomenon. GLP-1 receptor agonists slow gastric emptying, which changes how alcohol is absorbed. They also appear to reduce dopamine signaling in reward pathways, which may dampen the craving response. Klausen et al. (2022, JCI Insight) showed GLP-1 receptor activation reduced alcohol intake in rodent models, and there are ongoing human trials. This is real science, not bro-science.
What she got wrong, or at least oversimplified: the idea that her face being slimmer proves reduced systemic inflammation. That's not how you measure inflammation. CRP, ESR, cytokines, those are the markers. A slimmer face is visual, not clinical. She's stacking an anecdotal observation on top of a real mechanism and presenting them as the same thing. They're not.
She also uses "inflamed and bloated" interchangeably, but bloating is largely a gut motility issue, and tirzepatide slowing gastric emptying could actually worsen bloating in some people initially. That she feels better is great. That she's attributing it all to inflammation reduction is a stretch.
What should you actually know?
If you're considering tirzepatide and you're motivated by inflammation or "feeling puffy," here's what the evidence actually supports. Yes, GLP-1 and GIP receptor agonists have demonstrated anti-inflammatory effects in clinical trials, primarily in people with metabolic disease. Those effects appear to be partly weight-loss-dependent and partly independent. The "low and slow" dosing approach she describes aligns with the FDA-approved titration schedule, which starts at 2.5 mg for four weeks before any increase. That part is clinically sound.
The alcohol aversion she describes is worth taking seriously as a safety note, not just a fun side effect. GLP-1 medications alter gastric emptying, which changes alcohol absorption rates unpredictably. Drinking on these medications carries real risk of faster intoxication or GI distress, and that's not a feature to celebrate without context.
Finally, telehealth prescribers vary enormously in how they approach this medication. The "crunchy holistic meets Western medicine" provider she mentions isn't a clinical category. Make sure whoever is prescribing this to you is actually monitoring your metabolic markers, not just your weight.